Virtus ETF Advisers’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24,183
| Closed | -$72.5K | – | 435 |
|
|
2023
Q3 | $72.5K | Sell |
24,183
-2,403
| -9% | -$7.21K | 0.04% | 376 |
|
|
2023
Q2 | $99.4K | Buy |
26,586
+3,638
| +16% | +$13.6K | 0.06% | 382 |
|
|
2023
Q1 | $76.9K | Sell |
22,948
-8,814
| -28% | -$29.5K | 0.04% | 390 |
|
|
2022
Q4 | $153K | Buy |
31,762
+16,102
| +103% | +$77.5K | 0.08% | 340 |
|
|
2022
Q3 | $89K | Buy |
15,660
+112
| +0.7% | +$637 | 0.04% | 426 |
|
|
2022
Q2 | $110K | Sell |
15,548
-3,785
| -20% | -$26.8K | 0.04% | 407 |
|
|
2022
Q1 | $140K | Sell |
19,333
-1,148
| -6% | -$8.31K | 0.06% | 236 |
|
|
2021
Q4 | $183K | Buy |
20,481
+11,549
| +129% | +$103K | 0.07% | 239 |
|
|
2021
Q3 | $313K | Sell |
8,932
-463
| -5% | -$16.2K | 0.14% | 198 |
|
|
2021
Q2 | $202K | Buy |
+9,395
| New | +$202K | 0.08% | 338 |
|